WHITE PAPER
Testing the CAR Risk mitigation in autologous CAR-T therapy clinical trials in oncology
Jan 13, 2023
Download

Activity in the field of Cell and Gene Therapy (CAGT) has been steadily increasing as the techniques are refined, and patient selection and monitoring are standardized. This white paper builds on the first paper in the CAGT Hot Buttons series, “Introduction to Autologous CAR-T therapy”. Here, we discuss frequently encountered medical hazards of the most widely available autologous Chimeric Antigen Receptor T-cell (CAR-T) therapies in the B cell hematologic malignancy patient population.

Contact Us